{"id":"W4409814932","doi":"10.2174/0113892010367028250411111549","title":"Challenges and Pathways in Regulating Next-Gen Biological Therapies","year":2025,"lang":"en","type":"article","venue":"Current Pharmaceutical Biotechnology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Marketing authorization; Medicine; Genetic enhancement; Commercialization; Clinical trial; Authorization; Cell therapy; Genome editing; Disease; Biotechnology; Bioinformatics; Stem cell; Intensive care medicine; CRISPR; Gene; Business; Biology; Pathology; Genetics; Computer science; Marketing","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003637292,0.0001433526,0.0002951603,0.0002822117,0.00005071989,0.000008903021,0.00009401808,0.0006782237,0.00002505866],"category_scores_gemma":[0.0001211417,0.0001015981,0.00004510058,0.0002885694,0.001346937,0.00003099698,0.0001673243,0.0008750721,0.000005385966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004084512,"about_ca_system_score_gemma":0.00004811137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001024103,"about_ca_topic_score_gemma":0.000002394419,"domain_scores_codex":[0.9988575,0.00006874153,0.0002832794,0.0003849063,0.0001117483,0.0002938207],"domain_scores_gemma":[0.9995477,0.0001287203,0.00003582207,0.0001676324,0.0000305428,0.00008964108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005566624,0.0001370568,0.0005554298,0.0001352791,0.00001972197,0.000005349606,0.00009219132,7.896173e-8,0.04057924,0.195933,0.00001537201,0.7624716],"study_design_scores_gemma":[0.008145727,0.0006925078,0.1504979,0.001553977,0.0001516553,0.0001230729,0.001307071,0.01142093,0.06651794,0.2044339,0.554496,0.0006593242],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5901561,0.2144074,0.0005433936,0.1923598,0.0004616274,0.0005280586,0.000002985134,0.0002940774,0.001246586],"genre_scores_gemma":[0.9393117,0.05976486,0.0004126534,0.0004146995,0.00005327437,0.00001810669,0.000008702908,0.000005811375,0.00001019188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7618123,"threshold_uncertainty_score":0.5231082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2055594416591689,"score_gpt":0.4059389263711495,"score_spread":0.2003794847119806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}